Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,705.00
Bid: 1,650.00
Ask: 1,710.00
Change: 0.00 (0.00%)
Spread: 60.00 (3.636%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET PRE-OPEN: Natwest posts 2021 profit, plans share buyback

Fri, 18th Feb 2022 07:46

(Alliance News) - Stocks in London are set to steady on Friday at the end of a difficult week dominated by headlines about the Russia-Ukraine crisis.

In early UK economic data, the retail sector rebounded at the start of 2022 after a disappointing Omicron-hit December. UK retail sales rose 1.9% year-on-year in January after a 4.0% fall in December.

Sales were 3.6% above pre-pandemic levels at the start of 2022.

"It was a good month for garden centres, department and household goods stores, with particularly strong trading for furniture and lighting," said Darren Morgan, director of Economic Statistics at the Office for National Statistics.

Sterling was quoted at USD1.3625 early Friday, firm against USD1.3620 at the London equities close on Thursday.

In early company news, lender Natwest unveiled a GBP750 million share buyback programme as it swung to profit in 2021, and industrial property investor Segro topped net asset value forecasts.

IG says futures indicate the FTSE 100 index of large-caps to open up 15.73 points, or 0.2%, at 7,553.10 on Friday. The FTSE 100 closed down 66.41 points, or 0.9%, at 7,537.37 on Thursday.

"Yesterday saw another day of uncertainty and market declines on claims and counterclaims between Russia and NATO about the size and movement of Russian forces on the Ukrainian border," said Michael Hewson, chief market analyst at CMC Markets.

The US said Thursday that Russia is on the verge of unleashing a massive military attack against Ukraine, dismissing Moscow's claim to be pulling forces back, as artillery fire hit a Ukrainian kindergarten.

In a dramatic, previously unscheduled speech to the United Nations in New York, US Secretary of State Antony Blinken said intelligence showed Moscow could order an assault on its neighbour in the "coming days".

Russia denies any invasion plans but warned of "military-technical measures" if its far-reaching demands for a US and NATO pullback from eastern Europe aren't satisfied.

Investor sentiment took a hit from this in New York overnight, with the Dow Jones Industrial Average ending down 1.8%, the S&P 500 down 2.1%, and the Nasdaq Composite down 2.9%.

Losses moderated in the Asian session on Friday, however. The Nikkei 225 index in Tokyo closed down 0.4%. In China, the Shanghai Composite ended up 0.7%, but the Hang Seng index in Hong Kong was down 1.7% in late trade. The S&P/ASX 200 in Sydney fell 1.0%.

The US said late Thursday that Blinken and his Moscow counterpart Sergei Lavrov had agreed to meet next week – provided there was no invasion before then.

"This development looks set to see markets here in Europe open modestly higher on the basis that if the US and Russia continue to talk then the prospect of war has diminished for the time being," CMC's Hewson said.

In early UK company news, NatWest reported a profit for 2021 and said it plans to return GBP750 million to shareholders via a share buyback, and possibly even more.

Net interest income for 2021 rose 1.7% to GBP7.61 billion from GBP7.48 billion the year before, though a dip in non-interest income meant total income for the year was flat at GBP10.51 billion.

The lender swung to a pretax profit of GBP4.03 billion from a loss of GBP481 million the year before, benefiting from an impairment release of GBP1.28 billion versus an expense of GBP3.13 billion.

The impairment release "principally reflects releases in non-default portfolios and the low levels of realised losses we have seen across the year," the bank said.

Natwest laid out plans for a GBP750 million share buyback in the first half of 2022 and said it will consider further repurchases as part of its capital distribution approach. This was alongside a final dividend of 7.5p, more than double 3.0p the year before.

The state-controlled lender also said it will maintain capacity to participate in buybacks of shares held by the UK government.

For 2022, Natwest expects income excluding notable items to be above GBP11.0 billion in the 'go-forward group' - which excludes Ulster Bank RoI and discontinued operations - and it plans to invest around GBP3 billion over 2021 to 2023 while reducing operating costs.

"As our economy recovers and the trend towards digital services accelerates, we are investing to deliver long term value in the bank and drive sustainable growth. We will do this by building closer and deeper relationships with our customers and by supporting their evolving needs and expectations at every stage of their lives," said Chief Executive Alison Rose.

Warehouse property investor Segro reported an adjusted net asset value per share of 1,137 pence at the end of 2021, up 40% from 814p a year before. This beat company-compiled consensus of 998p.

Pretax profit for 2021 multiplied to GBP4.36 billion from GBP1.46 billion in 2020.

"2021 was a highly successful year for Segro as reflected in our full year results which include a GBP4.1 billion portfolio valuation uplift and record levels of rental growth. Investor and occupier supply-demand dynamics in the industrial and logistics sector remain very favourable, led by the long-term trends of digitalisation, supply chain resilience and an increasing focus on sustainability," said Chief Executive David Sleath.

GlaxoSmithKline said it has voluntarily paused enrolment and vaccination in the Grace phase three trial evaluating its potential respiratory syncytial virus maternal vaccine candidate, as well as two other trials investigating this candidate in pregnant women.

"This decision was made following a recommendation from the Independent Data Monitoring Committee based on an observation from a routine safety assessment. Monitoring safety signals is an integral part of the clinical development process for potential new vaccines," the pharmaceutical firm said, adding it will provide a further update in due course.

This decision does not affect the AReSVi 006 phase three trial for RSV older adults, with results from this study on track for the first half of 2022.

NortonLifeLock said it has postponed the closing of its merger with Avast to April, having been previously expected to close later this month.

NortonLifeLock said talks with competition bodies in the UK and Spain are ongoing. As a result of the delay, Avast said it plans to proceed with the payment of a 11.2 cent dividend. The closing is expected to be on April 4, delayed from February 24, with Avast shares delisted on April 5.

The euro traded at USD1.1372 early Friday, unchanged versus USD1.1370 late Thursday.

Against the yen, the dollar edged up to JPY115.06 from JPY115.02. The yen eased after data showed Japan's core consumer prices edged up just 0.2% in January, slightly less than expected, though the increase was the fifth monthly rise.

The core consumer price index, which excludes volatile fresh food prices but includes fuel costs, was up 0.2% in January year-on-year, following similar rises from September to December. The advance follows 18 months of declines or stagnation during the depths of the pandemic, but it fell slightly short of economist expectations for a 0.3% rise.

Safe-haven asset gold softened as risk mood improved into the end of the week. The shining metal was quoted at USD1,891.83 an ounce early Friday, lower than USD1,895.50 on Thursday.

Brent oil was trading at USD92.41 a barrel early Friday, soft on USD92.65 late Thursday.

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more
25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.